Global Rhabdomyosarcoma Drug Market Status and Outlook 2018-2025

July 2018 | 139 pages | ID: G8B1BB7DA7CEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Bellicum Pharmaceuticals Inc
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Co
• Celgene Corp
• Eisai Co Ltd
• Epizyme Inc
• Exelixis Inc
• Iproteos SL
• Ipsen SA
• MacroGenics Inc
• NantKwest Inc
• Novartis AG
• Noxxon Pharma AG
• Pfizer Inc
• Taiho Pharmaceutical Co Ltd
• Taiwan Liposome Company Ltd
• Tarveda Therapeutics Inc

Market by Type

• ARI-4175
• Celyvir
• Crizotinib
• Enoblituzumab
• AT-69
• Axitinib
• Others

Market by Application

• Research Center
• Hospital
• Clinic
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Rhabdomyosarcoma Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 ARI-4175
  3.1.2 Celyvir
  3.1.3 Crizotinib
  3.1.4 Enoblituzumab
  3.1.5 AT-69
  3.1.6 Axitinib
  3.1.7 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Research Center
  4.1.2 Hospital
  4.1.3 Clinic
  4.1.4 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 ARI-4175 Production by Region
    6.1.1.2 Celyvir Production by Region
    6.1.1.3 Crizotinib Production by Region
    6.1.1.4 Enoblituzumab Production by Region
    6.1.1.5 AT-69 Production by Region
    6.1.1.6 Axitinib Production by Region
    6.1.1.7 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Research Center Production by Region
    6.1.2.2 Hospital Production by Region
    6.1.2.3 Clinic Production by Region
    6.1.2.4 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 ARI-4175 Demand by Region
    6.2.1.2 Celyvir Demand by Region
    6.2.1.3 Crizotinib Demand by Region
    6.2.1.4 Enoblituzumab Demand by Region
    6.2.1.5 AT-69 Demand by Region
    6.2.1.6 Axitinib Demand by Region
    6.2.1.7 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Research Center Demand by Region
    6.2.2.2 Hospital Demand by Region
    6.2.2.3 Clinic Demand by Region
    6.2.2.4 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Bellicum Pharmaceuticals Inc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Boehringer Ingelheim GmbH
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Bristol-Myers Squibb Co
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Celgene Corp
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Eisai Co Ltd
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Epizyme Inc
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Exelixis Inc
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Iproteos SL
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Ipsen SA
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 MacroGenics Inc
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 NantKwest Inc
8.12 Novartis AG
8.13 Noxxon Pharma AG
8.14 Pfizer Inc
8.15 Taiho Pharmaceutical Co Ltd
8.16 Taiwan Liposome Company Ltd
8.17 Tarveda Therapeutics Inc

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Rhabdomyosarcoma Drug Industry Dynamics & Regulations List
Table Global Rhabdomyosarcoma Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Rhabdomyosarcoma Drug Market Status by Type 2015-2018E, in USD Million
Table Global Rhabdomyosarcoma Drug Market Status by Application 2015-2018E, in USD Million
Table Global Rhabdomyosarcoma Drug Market Status by Application 2015-2018E, in Volume
Table Global Rhabdomyosarcoma Drug Market by Region 2015-2018E, in USD Million
Table Global Rhabdomyosarcoma Drug Market Share by Region in 2018, in USD Million
Table Global Rhabdomyosarcoma Drug Market by Region 2015-2018E, in Volume
Table Global Rhabdomyosarcoma Drug Market Share by Region in 2018, in Volume
Table ARI-4175 Production Value by Region 2015-2018E, in USD Million
Table ARI-4175 Production Volume by Region 2015-2018E, in Volume
Table Celyvir Production Value by Region 2015-2018E, in USD Million
Table Celyvir Production Volume by Region 2015-2018E, in Volume
Table Crizotinib Production Value by Region 2015-2018E, in USD Million
Table Crizotinib Production Volume by Region 2015-2018E, in Volume
Table Enoblituzumab Production Value by Region 2015-2018E, in USD Million
Table Enoblituzumab Production Volume by Region 2015-2018E, in Volume
Table AT-69 Production Value by Region 2015-2018E, in USD Million
Table AT-69 Production Volume by Region 2015-2018E, in Volume
Table Axitinib Production Value by Region 2015-2018E, in USD Million
Table Axitinib Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Research Center Production Value by Region 2015-2018E, in USD Million
Table Research Center Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table ARI-4175 Market Size by Region 2015-2018E, in USD Million
Table ARI-4175 Market Size by Region 2015-2018E, in Volume
Table Celyvir Market Size by Region 2015-2018E, in USD Million
Table Celyvir Market Size by Region 2015-2018E, in Volume
Table Crizotinib Market Size by Region 2015-2018E, in USD Million
Table Crizotinib Market Size by Region 2015-2018E, in Volume
Table Enoblituzumab Market Size by Region 2015-2018E, in USD Million
Table Enoblituzumab Market Size by Region 2015-2018E, in Volume
Table AT-69 Market Size by Region 2015-2018E, in USD Million
Table AT-69 Market Size by Region 2015-2018E, in Volume
Table Axitinib Market Size by Region 2015-2018E, in USD Million
Table Axitinib Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Research Center Market Size by Region 2015-2018E, in USD Million
Table Research Center Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalRhabdomyosarcoma Drug Forecast by Type 2019F-2025F, in USD Million
Table Rhabdomyosarcoma Drug Forecast by Type 2019F-2025F, in Volume
Table Rhabdomyosarcoma Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Rhabdomyosarcoma Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Rhabdomyosarcoma Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Rhabdomyosarcoma Drug Market Forecast by Region 2019F-2025F, in Volume
Table Bellicum Pharmaceuticals Inc Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Bellicum Pharmaceuticals Inc
Table Boehringer Ingelheim GmbH Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Boehringer Ingelheim GmbH
Table Bristol-Myers Squibb Co Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Bristol-Myers Squibb Co
Table Celgene Corp Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Celgene Corp
Table Eisai Co Ltd Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Eisai Co Ltd
Table Epizyme Inc Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Epizyme Inc
Table Exelixis Inc Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Exelixis Inc
Table Iproteos SL Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Iproteos SL
Table Ipsen SA Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Ipsen SA
Table MacroGenics Inc Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of MacroGenics Inc
Table NantKwest Inc Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of NantKwest Inc
Table Novartis AG Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Novartis AG
Table Noxxon Pharma AG Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Noxxon Pharma AG
Table Pfizer Inc Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Pfizer Inc
Table Taiho Pharmaceutical Co Ltd Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Taiho Pharmaceutical Co Ltd
Table Taiwan Liposome Company Ltd Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Taiwan Liposome Company Ltd
Table Tarveda Therapeutics Inc Information
Table Rhabdomyosarcoma Drug Sales, Cost, Margin of Tarveda Therapeutics Inc
Table Global Rhabdomyosarcoma Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Rhabdomyosarcoma Drug Sales Volume by Company 2015-2017, in Volume
Table Global Rhabdomyosarcoma Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Rhabdomyosarcoma Drug Picture
Figure Rhabdomyosarcoma Drug Industry Chain Diagram
Figure Global Rhabdomyosarcoma Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Rhabdomyosarcoma Drug Sales Volume 2015-2018E, in Volume
Figure Global Rhabdomyosarcoma Drug Market Status by Type 2015-2018E, in Volume
Figure North America Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Rhabdomyosarcoma Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Rhabdomyosarcoma Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Rhabdomyosarcoma Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Rhabdomyosarcoma Drug Sales Price Forecast 2019F-2025F
Figure Global Rhabdomyosarcoma Drug Gross Margin Forecast 2019F-2025F
Figure Global Rhabdomyosarcoma Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Rhabdomyosarcoma Drug Price by Company in 2018
Figure Global Rhabdomyosarcoma Drug Gross Margin by Company in 2018